Kenya has officially passed the Assisted Reproductive Technology (ART) Bill, marking a significant step in regulating fertility treatments such as In Vitro Fertilisation (IVF), gamete donation, and surrogacy. This new legislation aims to bring clarity and protection to families seeking reproductive assistance while imposing key restrictions on various practices.
Under the new law, only Kenyans aged 25 to 55 are permitted to seek surrogacy, while surrogate mothers must be between 25 and 45 years old, have previously given birth, and clear medical and psychological assessments. One of the most notable aspects of the bill is its complete ban on the commercialization of surrogacy; surrogate mothers can only be reimbursed for reasonable expenses incurred during the process.
To enhance oversight and regulation, the Kenya Medical Practitioners and Dentists Council will establish a regulatory body responsible for licensing clinics, inspecting laboratories, and maintaining confidential national registers of donors and embryos. The law explicitly prohibits foreign couples from engaging in surrogacy services within Kenya, a stance aimed at preventing fertility tourism.
The ART Bill recognizes the legal rights of children born through assisted reproductive technologies, treating them equally to those conceived naturally. However, one controversial provision is the anonymity of sperm and egg donors, meaning that individuals conceived through donation will not have access to their biological parents’ identities.
While the new law provides much-needed structure, it raises ethical questions about potential exploitation of surrogate mothers, particularly in a country where economic disparities exist. Critics warn that without the possibility of compensation, some surrogates may pursue informal payments, leading to challenges seen in other nations that have outlawed paid surrogacy.
Comparatively, the Kenyan law stands in contrast to practices in countries like South Africa, where more inclusive policies accommodate single individuals and same-sex couples seeking surrogacy. In countries like France and Germany, stringent regulations limit or prohibit commercial gamete donation altogether.
The ART Bill represents an important move towards modernizing reproductive health rights in Kenya. However, as the law is implemented, attention will need to be directed toward its effects on families, surrogate mothers, and the ethical landscape of assisted reproductive technologies in the country. The coming months will reveal how effectively this legislation addresses the complex needs of those seeking fertility services in Kenya.
About The Author
